Study of mucocutaneous manifestations of HIV and its relation to total lymphocyte count.
Cutaneous manifestations
HIV
total lymphocyte count
Journal
Indian journal of sexually transmitted diseases and AIDS
ISSN: 2589-0565
Titre abrégé: Indian J Sex Transm Dis AIDS
Pays: India
ID NLM: 101730896
Informations de publication
Date de publication:
Historique:
received:
24
06
2016
accepted:
14
11
2017
entrez:
16
10
2020
pubmed:
17
10
2020
medline:
17
10
2020
Statut:
ppublish
Résumé
HIV is associated with various mucocutaneous manifestations which may be the first pointers toward HIV and can also be prognostic markers for disease progression. This study was done to note the different mucocutaneous lesions present in HIV and their relation to total lymphocyte count (TLC). Three hundred and seventy-nine HIV patients attending the Department of Dermatology, Venereology, and Leprosy were included in the study. They were screened for the presence of any mucocutaneous lesions. TLC in patients presenting with mucocutaneous lesions was done and also CD4 count was done wherever possible. Among 379 patients, 53.8% developed mucocutaneous manifestations. Male: female ratio was 2.2:1. Majority of patients belonged to 20-39 years age group. Among mucocutaneous manifestations, oral candidiasis was the most common, followed by herpes zoster and dermatophytoses. Adverse drug reactions were noted in few. The majority of patients had TLC <1500/mm Mucocutaneous manifestations are common and have varied presentation in HIV/AIDS. Patients with mucocutaneous manifestations were clustered at lower TLC and CD4 count. Like CD4 count, TLC can be considered as a marker for disease progression.
Identifiants
pubmed: 33062982
doi: 10.4103/ijstd.IJSTD_58_16
pii: IJSTD-41-47
pmc: PMC7529186
doi:
Types de publication
Journal Article
Langues
eng
Pagination
47-52Informations de copyright
Copyright: © 2018 Indian Journal of Sexually Transmitted Diseases and AIDS.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Indian J Dermatol Venereol Leprol. 1997 Jan-Feb;63(1):35-7
pubmed: 20944256
Int J Dermatol. 2005 Aug;44(8):646-9
pubmed: 16101864
Clin Infect Dis. 2003 Jan 1;36(1):79-85
pubmed: 12491206
Indian J Dermatol Venereol Leprol. 1996 Sep-Oct;62(5):331-2
pubmed: 20948109
J Assoc Physicians India. 2006 Jan;54:57-74
pubmed: 16649742
J Am Acad Dermatol. 1997 Feb;36(2 Pt 1):262-4
pubmed: 9039183
J Am Acad Dermatol. 1991 Feb;24(2 Pt 1):231-5
pubmed: 2007668
J Infect. 1987 Jan;14(1):1-5
pubmed: 3546510
Int J Dermatol. 2006 Mar;45(3):280-4
pubmed: 16533229
Indian J Med Res. 2005 Apr;121(4):377-94
pubmed: 15817951
Indian J Dermatol Venereol Leprol. 1996 Sep-Oct;62(5):283-5
pubmed: 20948090
Indian J Dermatol Venereol Leprol. 2002 Jul-Aug;68(4):213-6
pubmed: 17656940
Tuber Lung Dis. 1992 Dec;73(6):311-21
pubmed: 1292709
Arch Dermatol. 1989 Mar;125(3):357-61
pubmed: 2522293
Br J Dermatol. 1998 Jul;139(1):33-9
pubmed: 9764146
Indian J Dermatol Venereol Leprol. 2001 Mar-Apr;67(2):72-4
pubmed: 17664712
Indian J Dermatol Venereol Leprol. 2006 Jul-Aug;72(4):286-9
pubmed: 16880575
Indian J Dermatol Venereol Leprol. 2001 Mar-Apr;67(2):66-8
pubmed: 17664710
Indian J Dermatol Venereol Leprol. 2003 Mar-Apr;69(2):100-3
pubmed: 17642847
Indian J Dermatol Venereol Leprol. 2004 Mar-Apr;70(2):82-6
pubmed: 17642571
Am J Med Sci. 2004 Jul;328(1):57-63
pubmed: 15254442
Int J Dermatol. 2000 Oct;39(10):746-53
pubmed: 11095193
Int J Dermatol. 2000 Mar;39(3):192-5
pubmed: 10759958